Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)

Withdrawn before enrolling

Conditions studied: Heart Failure

In brief

A research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices

Key facts

Study ID

NCT02026635

Run by

Thomas Jefferson University

People needed

0

Starts

2013-09-01

Expected to finish

2015-02-01

Last updated by the study team

2015-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age
• Admission for worsening of HF
• Discharged to home
• Have appropriate cardiac device with OptiVol® implanted for at least 34 days prior to enrollment
• Enrolled in Carelink® system and able to transmit data
• Able to participate for at least 3 months

You may not qualify if…

• Post heart transplant or actively listed
• End-stage (Stage D) HF, including treatment with chronic ionotropic drugs or left ventricular assist device support
• Stage IV or V chronic renal dysfunction (GFR <25 mol/min per 1.73 M2)
• Severe Chronic Obstructive Pulmonary Disease (COPD) requiring home oxygen
• Severe pulmonary hypertension not due to left-sided HF

Where it is running

• Thomas Jefferson University — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.